Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alibaba
BABA
$269B
| $709M | 0.38% |
4,302,283
-309,908
| -7% | -$54.8M |
|
52
Sensata Technologies
ST
$6.65B
| $696M | 0.37% |
14,040,479
-304,535
| -2% | -$15.9M |
|
53
Netflix
NFLX
$292B
| $690M | 0.37% |
18,439,380
+3,059,480
| +20% | +$111M |
|
54
Accenture
ACN
$89.9B
| $688M | 0.37% |
4,040,414
+152,610
| +4% | +$25.4M |
|
|
AET
55
DELISTED
Aetna Inc
AET
| $673M | 0.36% |
3,319,092
+9,581
| +0.3% | +$1.87M |
|
56
Air Products & Chemicals
APD
$66.3B
| $670M | 0.36% |
4,011,060
-20,356
| -0.5% | -$3.31M |
|
57
Starbucks
SBUX
$118B
| $663M | 0.35% |
11,656,823
-1,482,273
| -11% | -$78.4M |
|
58
Booking.com
BKNG
$138B
| $648M | 0.35% |
8,163,175
-2,755,725
| -25% | -$217M |
|
59
LPL Financial
LPLA
$26.3B
| $640M | 0.34% |
9,921,681
-65,577
| -0.7% | -$4.35M |
|
60
Lamar Advertising Co
LAMR
$16.2B
| $640M | 0.34% |
8,221,199
-55,618
| -0.7% | -$4.14M |
|
61
Union Pacific
UNP
$183B
| $636M | 0.34% |
3,907,883
-1,618,399
| -29% | -$244M |
|
62
Norwegian Cruise Line
NCLH
$8.89B
| $632M | 0.34% |
11,002,326
+934,851
| +9% | +$48.4M |
|
63
Verisk Analytics
VRSK
$26.4B
| $630M | 0.34% |
5,222,219
+223,424
| +4% | +$26M |
|
|
ATHN
64
DELISTED
Athenahealth, Inc.
ATHN
| $629M | 0.34% |
4,711,553
-76,305
| -2% | -$11.4M |
|
65
US Bancorp
USB
$99.6B
| $629M | 0.34% |
11,918,220
-228,248
| -2% | -$12.1M |
|
66
Regeneron Pharmaceuticals
REGN
$68.8B
| $623M | 0.33% |
1,542,041
-260,699
| -14% | -$99.2M |
|
67
Amdocs
DOX
$5.53B
| $621M | 0.33% |
9,409,175
+1,005,564
| +12% | +$66.5M |
|
68
Johnson & Johnson
JNJ
$635B
| $610M | 0.33% |
4,413,726
-470,272
| -10% | -$62.5M |
|
69
Sherwin-Williams
SHW
$78.3B
| $610M | 0.33% |
4,017,813
-74,928
| -2% | -$11.1M |
|
70
Revvity
RVTY
$12.3B
| $604M | 0.32% |
6,206,910
-152,184
| -2% | -$13.1M |
|
71
Flex
FLEX
$43.4B
| $593M | 0.32% |
59,967,072
+574,161
| +1% | +$6.01M |
|
72
Aon
AON
$77.3B
| $582M | 0.31% |
3,785,012
-345,829
| -8% | -$50.6M |
|
73
Nice
NICE
$5.29B
| $582M | 0.31% |
5,084,193
+48,091
| +1% | +$5.38M |
|
74
JPMorgan Chase
JPM
$939B
| $580M | 0.31% |
5,136,427
+3,803
| +0.1% | +$432K |
|
75
LyondellBasell Industries
LYB
$19.5B
| $579M | 0.31% |
5,649,960
+186,039
| +3% | +$20.3M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.